Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of RN-0001 for prevention of acute kidney injury after cardiopulmonary bypass cardiac surgery
CTR20230361Phase 2Completed
- Sponsor
- Ruinuo Medical Technology
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of RN-0001, sponsored by Ruinuo Medical Technology. Started May 2023; status: completed.
02
Drugs
RN-0001
Beyond the preview
Go deeper on CTR20230361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230361.